Murine Melanoma Tumor
Murine Melanoma Tumor - Related Videos
10:23
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
0 Views •
Cited by 32 •
2012
A rapid way to screen for melanoma modifiers using a zebrafish autochthonous tumor model is presented. It takes advantage of the miniCoopR vector which allows for expression of candidate melanoma genes in melanocytes. A method to obtain melanoma-free survival curves, an invasion assay, a protocol for antibody staining of scale melanocytes and a melanoma transplantation assay are described.
07:31
Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
0 Views •
Cited by 13 •
2016
Metastasis plays a profound role in the virulence of cancer, accounting for an estimated 90% of deaths. We report a protocol for a metastatic melanoma model in mice that is useful for determining the efficacy of therapeutic agents against this clinical phenomenon.
10:03
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
0 Views •
Cited by 6 •
2016
The goal of this protocol is to show the protocol for reprogramming melanoma tumor-infiltrating lymphocytes into induced pluripotent stem cells.
03:52
Experimental Metastatic Melanoma Mouse Model: A Platform to Study the Metastatic Potential of Melanoma Cells in the Lungs
0 Views •
2023
In this video, melanoma cells are intravenously injected through the tail vein in the mouse model. The melanoma cells further travel through the circulatory system, adapting to the distant microenvironment and causing metastasis in organs like lungs.
04:07
miniCoopR Vector-based Transgenesis: A Technique to Screen Melanoma-inducing Genes in Zebrafish Tumor Model
0 Views •
2023
This video describes a method to screen for the melanoma modifying genes using a transgenic zebrafish tumor model. When injected with a melanoma-inducing miniCoopR vector, the zebrafish develops melanomas and can therefore be used to study the genetic factors affecting tumor development in zebrafish.
FAQs
Melanoma cells interact with surrounding tissue in ways that influence immune regulation. They may recruit immune cells, alter how those cells function, or evade immune recognition and attack. Studying these interactions helps researchers identify features of the tumor microenvironment that support tumor persistence and may reveal mechanisms that limit effective antitumor immunity.
Immune suppression can prevent immune cells from recognizing or eliminating malignant cells efficiently. A murine melanoma tumor provides a controlled setting for examining how suppression develops within the tumor microenvironment and how it affects tumor growth or treatment response. These observations can support strategies designed to improve immune recognition and cancer-cell elimination.
Treatment-response studies can connect therapeutic intervention with changes in tumor growth, immune regulation, and immune-mediated attack. Researchers can assess whether an intervention is associated with stronger antitumor activity or altered immune behavior. This makes the model useful for investigating why some approaches improve elimination of malignant cells while others fail to overcome immune suppression.
Infectious factors may alter immune function within the tumor setting, changing how immune cells interact with malignant cells or respond to treatment. Including this context allows researchers to examine connections between infection-related immune changes and tumor control. Such studies can clarify whether altered immune regulation influences recognition, immune-mediated attack, or therapeutic responses.
The process begins by establishing a tumor from melanoma cells in mice. Researchers then monitor tumor development while examining interactions between malignant cells and the surrounding tissue. Depending on the study question, they evaluate immune regulation, immune-cell recruitment or evasion, and responses to immune-mediated attack or therapeutic intervention.
Key outcomes include tumor growth, immune regulation, immune-cell interactions, and response to treatment. Investigators can examine whether malignant cells recruit or evade immune cells and whether an intervention changes immune-mediated attack. Together, these observations provide evidence about the tumor microenvironment and help identify factors associated with stronger or weaker antitumor responses.
These tumors are useful when researchers need to assess how an intervention affects both malignant growth and immune activity in a controlled mouse model. Studies can examine treatment responses alongside immune suppression, immune-cell recruitment, or immune-mediated attack. The resulting findings may guide strategies intended to improve recognition and elimination of cancer cells.